Maciej J. Zamek‐Gliszczynski

Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the Liver

Maciej J. Zamek‐Gliszczynski, Hao Xiong, Nita Patel et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 169 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Identification of LY2510924, a Novel Cyclic Peptide CXCR4 Antagonist That Exhibits Antitumor Activities in Solid Tumor and Breast Cancer Metastatic Models

Sheng-Bin Peng, Xiaoyi Zhang, Donald C. Paul et al. · Molecular Cancer Therapeutics · 2014 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects

Ivy Song, Jian Zong, Julie Borland et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 121 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Evaluation of the Role of Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 in Hepatic Basolateral Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Abcc3–– and Abcc4–– Mice

Maciej J. Zamek‐Gliszczynski, Ken-ichi Nezasa, Xianbin Tian et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 120 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice

Maciej J. Zamek‐Gliszczynski, Ken-ichi Nezasa, Xianbin Tian et al. · Molecular Pharmacology · 2006 · 112 citations

Pharmacy, Pharmacokinetics, Pharmacology +16